Navigation Links
Diagenode Launches Novel CRISPR/Cas9 Monoclonal Antibody
Date:8/8/2014

Denville, NJ (PRWEB) August 08, 2014

Diagenode, Inc., a leading global provider of complete solutions for epigenetics research, recently launched the industry’s first monoclonal antibody targeting CRISPR/Cas9. The antibody has been extensively validated for a number of applications including western blotting, immunofluorescence to determine protein localization, and immunoprecipitation applications such as chromatin immunoprecipitation.

The CRISPR/Cas system has been most commonly used for gene editing such as in gene silencing or changing specific genes in both bacterial systems and eukaryotic systems. In addition, Cas9 can also be used to mediate upregulation or downregulation of specific endogenous genes or to alter histone modifications or DNA methylation. The new monoclonal antibody will allow researchers to supplement their CRISPR/Cas studies.

“Diagenode has been a long time supplier of highly sensitive and specific validated epigenetic antibodies. We are pleased to offer the first monoclonal CRISPR/Cas9 antibody for epigenetic applications as well as a variety of other validated methods,” stated Didier Allaer, CEO of Diagenode. “The new CRISPR/Cas9 antibody is superior to epitope-tagged antibodies as it provides a much higher sensitivity.”

More information on Diagenode’s CRISPR/Cas9 antibody validation and other epigenetic-focused antibodies can be found at http://www.diagenode.com/en/landing-pages/CAS9-monoclonal-antibody.php.

About Diagenode, Inc.:
Diagenode is a leading provider of complete solutions for epigenetic research. The company has developed a comprehensive approach to gain new insights into epigenetic studies, offering innovative shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include a unique, full automation system, ChIP-seq kits for only 10,000 cells, and the industry’s most validated antibodies. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12081848.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Diagenode Introduces Innovative Bioruptor® Pico for Micro-Volume Chromatin and DNA Shearing
2. Rice Lake Weighing Systems Launches Customized Test Weight Set: Essential Weights™
3. Sales Horizons Launches a New Online Sales Training Course for Technical, Engineering, and IT Staff to Develop Sales Awareness and Their Sales Skills
4. Glencoe Software Launches Data InPress
5. The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies
6. Grace Launches New REVELERIS® Prep Purification System
7. Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales
8. SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative
9. Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com
10. Dr. J. J. Wendel Launches New Line of Skin Care Products
11. BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics Advanced Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... , ... Stratevi, a boutique firm that partners with healthcare companies to creatively ... office in downtown Boston at 745 Atlantic Ave. , “We are seeing that ... on the value they provide, not just to patients, but also payers. Having a ...
(Date:5/21/2017)... ANGELES, CA (PRWEB) , ... May 19, 2017 ... ... the annual meeting and educational conference of the American Association of Bioanalysts (AAB) ... the Galleria Hotel in Houston. The conference reinforces AAB’s commitment to excellence in ...
(Date:5/19/2017)... ... May 19, 2017 , ... The University City Science ... technologies ripe for commercialization, and who are affiliated with the 21 partner academic ... proposals. QED, now in its tenth round, is the first multi-institutional proof-of-concept program ...
(Date:5/18/2017)... ... ... Clinical Supplies Management (“CSM”), a Great Point Partners II (“GPP”) portfolio company, today announced ... in size over the past six months with the acquisition of businesses in Belgium ... as Chief Financial Officer. Roger has over 25 years of experience in finance ...
Breaking Biology Technology:
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/16/2017)... Germany , March 16, 2017 CeBIT 2017 - Against identity ... Continue Reading ... Used combined in one project, multi-biometric solutions provide ... Used ... Systems) ...
Breaking Biology News(10 mins):